Tryp Therapeutics closes the second tranche of its recently announced private placement for gross proceeds of CAD$3 million. Units are priced at CAD$0.15.
Psychedelics
Psychedelic Drug Patenting: Still Only Scratching The Surface
Dozens of psychedelic drugs to research. Several "generations" of R&D ahead. To say that we're early in the game with psychedelic drug research is an understatement.
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
Cybin announces a new clinical partner as it prepares for its Phase 1/2a clinical trial for CYB003.
Revitalist Reports Fourteen Months of Consecutive Monthly Visit Growth and a 466% Increase Year over Year for March 2022
Revitalist Lifestyle and Wellness announces 14th consecutive month of revenues growth and projects further growth across its network of 9 clinics.
Looking For The Perfect Inflation Hedge? Try This Company
Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.
Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds
Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.
Mydecine Announces Reverse Stock-Split
Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.
Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands
Red Light Holland to sponsor a "microdosing concert" in The Netherlands, given by mezza-soprano Helena van Heel.
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway
Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research
Numinus Wellness is acquiring Novamind Inc in an all-share deal valued at CAD$26.2 million, creating an industry leader in research AND treatment.
How Minera Alamos Turns $20 Of Exploration Spending Into $2,000 Of Gold
From exploration right through to production, Minera Alamos epitomizes efficiency in gold mining.
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom Farms Division Expands in North America
Red Light Holland announces the purchase of 100 acres of farmland in Ontario that it is targeting for mushroom cultivation.
Red Light Holland Appoints New Chief Marketing Officer
Red Light Holland's new Chief Marketing Officer, Ridley Doolittle, has extensive experience in brand development, including a senior position with Bacardi.
Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules
Cybin announces the publication bu WIPO of Cybin's patent application for psychedelics-based delivery systems.
Revitalist Announces Private Placement Offering of up To CDN$6 Million
Revitalist announces a CAD$6 million private placement of convertible notes and warrants. Notes can be converted into common shares at a price of CAD$0.15.